XRAY (Dentsply Sirona) 3-Year RORE % : 27.57% (As of Mar. 2026)


XRAY Dentsply Sirona Inc XRAY
55 GF Score
Price $11.65
GF Value $19.04
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Dentsply Sirona 3-Year RORE %?

Dentsply Sirona XRAY +4.95% 55 3-Year RORE % is 27.57 as of Mar. 2026. GuruFocus rates XRAY with a GF Score™ of 55/100 and a GF Value™ of $19.04 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 781 Medical Devices & Instruments companies, Dentsply Sirona ranks better than 78.49% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Dentsply Sirona's 3-Year RORE % for the quarter that ended in Mar. 2026 was 27.57%.

The industry rank for Dentsply Sirona's 3-Year RORE % or its related term are showing as below:

XRAY's 3-Year RORE % is ranked better than
78.49% of 781 companies
in the Medical Devices & Instruments industry
Industry Median: -4.27 vs XRAY: 27.57

Dentsply Sirona  (NAS:XRAY) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Dentsply Sirona 3-Year RORE % Related Terms


Dentsply Sirona 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Dentsply Sirona's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dentsply Sirona 3-Year RORE % Chart

Dentsply Sirona Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.79 92.20 50.84 1.15 23.78

Dentsply Sirona Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.51 -0.25 36.65 23.78 27.57

XRAY vs LMAT, PLSE, KMTS: 3-Year RORE % Comparison

For the Medical Instruments & Supplies subindustry, Dentsply Sirona's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dentsply Sirona 3-Year RORE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Dentsply Sirona's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Dentsply Sirona's 3-Year RORE % falls into.


XRAY
55GF Score
Dentsply Sirona Inc XRAY
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dentsply Sirona 3-Year RORE % Calculation

Dentsply Sirona's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -3.15--0.44 )/( -8.13-1.7 )
=-2.71/-9.83
=27.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 27.57 mean?
Dentsply Sirona (XRAY) has a 3-Year RORE % of 27.57 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Dentsply Sirona and its competitors. According to the industry distribution chart, Dentsply Sirona ranks #168 out of 781 companies in the Medical Devices & Instruments industry, placing it in the top 21.5%.
Is Dentsply Sirona's 3-Year RORE % too high?
Dentsply Sirona's current 3-Year RORE % is 27.57. Based on the distribution chart, Dentsply Sirona ranks #168 out of 781 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Dentsply Sirona has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dentsply Sirona's 3-Year RORE % compare to LMAT and PLSE?
According to the Medical Devices & Instruments industry distribution chart, Dentsply Sirona ranks #168 out of 781 companies for 3-Year RORE %. This places Dentsply Sirona in the top 22% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Dentsply Sirona and its competitors. Dentsply Sirona's current 3-Year RORE % is 27.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dentsply Sirona stock overvalued right now?
Based on GuruFocus' analysis, Dentsply Sirona (XRAY) is currently considered Possible Value Trap. The stock's GF Value™ is $19.04, compared to a current price of $11.65 — trading 38.8% below its estimated fair value. The current 3-Year RORE % is 27.57. Dentsply Sirona's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Dentsply Sirona (XRAY), the current 3-Year RORE % is 27.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dentsply Sirona (XRAY) Overvalued in 2026?

Based on GuruFocus' analysis, Dentsply Sirona stock appears to be undervalued. The current stock price of $11.65 is trading 38.8% below its estimated GF Value™ of $19.04. GuruFocus considers Dentsply Sirona to be Possible Value Trap.

Key valuation signals for XRAY:

  • 3-Year RORE %: 27.57
  • GF Value™: $19.04 vs. price of $11.65 (38.8% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the XRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dentsply Sirona Business Description

Address 13320 Ballantyne Corporate Place, Charlotte, NC, USA, 28277-3607
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
55GF Score

Get the complete analysis for XRAY

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.65
Price
$19.04
GF Value